MRV Research

Several cancer susceptibility variants also affect melanoma risk

MRV Research

Pleiotropy refers to a single genetic locus having multiple phenotypic effects. Evidence of pleiotropy can suggest shared molecular mechanisms or disease susceptibility pathways between phenotypes. Several regions of the genome demonstrate pleiotropic effects with multiple cancers, but the extent of these pleiotropic relationships has not been fully characterized.

Read More

Melanoma-Activating Beta-Catenin Signalling Prevents Immune System Activation

In a new study entitled “Melanoma-intrinsic beta-catenin signaling prevents anti-tumor immunity,” a research team at University of Chicago unraveled the mechanism by which melanoma tumors are able to resist to the most effective immunotherapies currently available. These findings identify new candidate targets for developing immune tools to overcome tumor immune evasion pathways. The study was published in the May 11, 2015 issue of Nature.

Read More

The ongoing battle with melanoma

Malignant melanoma – a type skin cancer – is almost always curable when it’s found in its very early stages. Unfortunately, it’s far more aggressive than other skin cancers and often becomes metastatic – spreading to other parts of the body. When it reaches this stage, it becomes almost untreatable, and is nearly always fatal.

Read More

DNA Repair Mapped by UNC Researchers

Groundbreaking work in mapping damaged DNA repair in the human genome reached a milestone at the University of North Carolina School of Medicine and Lineberger Comprehensive Cancer Center. The new study may have implications in helping treat patients with melanoma whose cells have become cancerous due to UV radiation damage and have overcome common chemotherapy agents through DNA repair.

Read More
MRV News
Melanoma News
Archive
Menu